ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Imraldi 40 mg/0.4 ml, Injektionslösung in einer Fertigspritze - 6
67427006 Samsung Bioepis CH GmbH
Imraldi 40 mg/0.4 ml, Injektionslösung in einer Fertigspritze03.04.2020
  18.12.2024
Adalimumab (L04AB04) 
WHO-DDD 
07.15.6
07.15. 
B  
Yes 
IP 
2080.98Yes
    
10 %2281.00
7680674270065Biotechnologika
  
Composition
adalimumabum 40 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, acidum succinicum, dinatrii succinas, histidinum, histidini hydrochloridum monohydricum, mannitolum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.4 ml corresp. natrium 0.08 mg.
Packungsbestandteile
Injection solution in prefilled syringe 
  
 
Active AgentDose
Adalimumab40mg / 0.4ml
BAG: Active AgentDose
Adalimumab40 mg
 
Inactive agents
Succinic Acid
Disodium Phosphate Heptahydrate
Dinatrii Succinas
Histidin Hydrochloride Monohydrate
Histidine
Mannitol
Sodium Dihydrogenophosphate Monohydrate
Polysorbatum 20
 
Source
Data was imported : 07.01.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home